RSV news
@RSVnewsSearching and sharing latest #RSV epidemiology, virology, diagnostics and clinical news.
Similar User
@ReSViNET
@rsvpatients
@IsirvEpi
@sbdrysdale
@Cambridge_SBS
@ESWInfluenza
@ESPIDsociety
@PIDJournal
@_VaccineSafety
@isirvAVG
@WHOCCFluMelb
@SEIMC_
@InThwaiteImmune
@sev_virologia
@uk_icn
Ya está aquí el virus de la GRIPE haciendo de las suyas, como cada invierno (excepto durante la pandemia) ¿Qué sabemos de este virus? ¿Cómo nos infecta y como nos defendemos? ¿Por qué parece que nos hubiese atropellado un camión? 🦠🦠👇👇👇👇
Long🧵 #COVID19 and where we are. I’m worried. We are entering the 5th year of the pandemic and we are certainly in a different phase. This phase is marked by an evolving virus (with the XBB and BA.2 sublineages circulating and JN.1 becoming dominant). x.com/mvankerkhove/s…
Jab could cut RSV hospital admissions in babies by 80%, study finds theguardian.com/society/2023/d…
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM nejm.org/doi/full/10.10…
Proud to be part of this pivotal moment in #RSV history. Thanks to fantastic collaborators working tirelessly to individually randomise >8000 infants, the pragmatic #HARMONIE trial showed that #nirsevimab can prevent 8 of 10 infant hospitalisations
Nirsevimab, a monoclonal antibody targeting RSV, led to decreased hospitalizations for RSV-associated lower respiratory tract infection in infants during their first RSV season, in an open-label, pragmatic trial. Read the full HARMONIE trial results: nej.md/4au8JD5
Trial data published this week @NEJM supports real world data from Galicia on the effectiveness of Nirsevimab bbc.co.uk/news/health-67…
This study showed clear associations between RSV and ALRI in young children in sub-Saharan Africa, indicating the need for prophylactic measures against RSV in this age group. @RSVnews @rsvpatients @ESWInfluenza @ESCMID @ sciencedirect.com/science/articl… @RSVnews @GlobalVirusN @ISARIC1
Infants with RSV infection were significantly sicker post-pandemic- see our new paper just published in JAMA peds @BrenesHelena @katiahalabi @RSVnews @StJudeResearch @NCHforDocs jamanetwork.com/journals/jamap…
Protecting babies from #RSV this holiday season. Thousands of kids a year are hospitalized each year with RSV. #RSNA23 abcnews.go.com/Health/protect…
#Nirsevimab inmunización coverage in newborns in Spain so far: 93% Madrid, 91% Murcia (87% catch up <6m), Galicia 93% (86% <6m), Andalucía 93%. Wow! #RSV #FightBronchiolitis
🧵1/5 Publication alert 🚨 A population-wide analysis of #RSV hospital burden in children ≤2 years in Germany 🇩🇪 We analyzed publicly available data and found that RSV is a major cause of LRTI and SARIs in young children, especially in infants
| In Memory of Dr. John Paget | 📢@Promise_IMI ‘European #RSV Surveillance Bulletin Reporting Week 44/2023: ➡️RSV activity is increasing in most countries. ➡️France & the Netherlands reported RSV type A was dominant whilst for Slovenia, RSV type B. 👉imi-promise.eu/surveillance/p…
From science to policy: great to see the impact of IMI @RESCEUproject's collaborative work. Burden of #RSV disease evidence, as well as cost effectiveness models were used to support JCVI decision @IHIEurope
Demonstrates criticality of real time prospective data collection for health policy decisions JCVI also acknowledged importance of our BronchSTART study in their decision on the RSV vaccination programme Why network research from @PERUKItweep vital! gov.uk/government/pub…
Most of the deaths due to #RSV occur in #developingcountries. This means they occur in the community, they don't even reach the hospital. RSV infection is no joke. #tipicosantiago @ESPIDsociety @seipweb
If you know, you know💉 More than thrilled to give the first infant #RSV vaccine today. With an almost 80% reduction of hospitalization and provider visits for RSV, this will be life changing for families with infants less than 8 mo of age🎉 #pediatrics #tweetiatrician
Continued low #RSV transmission in outpatient setting in the summer of 2021 and 2022 journals.lww.com/pidj/fulltext/…
PROMISE poster @PROMISE_IMI at the ESCV congress @ESCVirology Congratulations to the Danish team @TheaKFischer
Good news. RSV activity clearly on the decline in Japan🇯🇵 (see Figure) and season heading to an end @KawasakiKR11 ▶️ Data from the National Institute of Infectious Diseases in Japan
Respiratory Syncytial Virus Infection: Old Challenges and New Approaches 🆓 Freely Available bit.ly/3Yd6LAa
What a moment in #RSV history. I am excited to see the impact this winter — will hospitals / paediatricians finally be relieved? Its not just the US, other countries have also evaluated nirsevimab data 🧵
CDC recommends use of nirsevimab to protect infants younger than 8 months & some older babies at high risk from severe respiratory syncytial virus (#RSV). Nirsevimab gives "parents a powerful tool to protect their children against RSV,” @CDCDirector bit.ly/3OGcb4x
United States Trends
- 1. #FridayVibes 5.091 posts
- 2. Good Friday 55,6 B posts
- 3. CONGRATULATIONS JIMIN 235 B posts
- 4. #FridayMotivation 8.761 posts
- 5. #NoMikeRogers 1.092 posts
- 6. Pam Bondi 296 B posts
- 7. #2024MAMA 1,04 Mn posts
- 8. Mnet 381 B posts
- 9. Memefi 30 B posts
- 10. Donny Dough N/A
- 11. Browns 112 B posts
- 12. Finally Friday 2.843 posts
- 13. Victory Friday N/A
- 14. #FridayFeeling 2.777 posts
- 15. CONGRATULATIONS JUNGKOOK 93,5 B posts
- 16. Happy Friyay 2.280 posts
- 17. Chris Brown 27,1 B posts
- 18. Jameis 63,2 B posts
- 19. Lakers 57 B posts
- 20. Wizkid 788 B posts
Who to follow
-
ReSViNET
@ReSViNET -
ReSViNetRSVPatientNetwork
@rsvpatients -
ISIRV_Epi_Group
@IsirvEpi -
Simon Drysdale
@sbdrysdale -
School of Biological Sciences
@Cambridge_SBS -
ESWI
@ESWInfluenza -
ESPIDSociety
@ESPIDsociety -
Ped Infect Diseases
@PIDJournal -
Vaccine Safety Initiative
@_VaccineSafety -
isirv antiviral
@isirvAVG -
WHO CC Influenza Melbourne
@WHOCCFluMelb -
SEIMC
@SEIMC_ -
Ryan Thwaites
@InThwaiteImmune -
SEV Virología
@sev_virologia -
UK-ICN
@uk_icn
Something went wrong.
Something went wrong.